Stem Cell Therapy for Diabetic Erectile Dysfunction in Rats: A Meta-Analysis.

Area of Science:

• Regenerative Medicine
• Urology
• Endocrinology

Background:

• Diabetic erectile dysfunction (ED) is a significant complication of diabetes.
• Stem cell therapy presents a novel treatment approach for diabetic ED.
• Animal studies in rats have explored the efficacy of stem cell therapy for diabetic ED.

Purpose of the Study:

• To compare the efficacy of different stem cell therapies for diabetic ED in rats.
• To identify factors influencing stem cell therapy outcomes.
• To determine optimal stem cell strategies for diabetic ED.

Main Methods:

• A systematic literature search was conducted on PubMed, Web of Science, and EBSCO for studies published before September 30, 2015.
• A random effects meta-analysis and subgroup analysis were performed on 10 studies involving 302 rats.
• Outcomes measured included intracavernous pressure (ICP)/mean arterial pressure (MAP) ratio and cavernous body structure.

Main Results:

• Stem cell therapy significantly improved erectile function in diabetic rats (SMD 4.03).
• Treatment increased smooth muscle and endothelial content, eNOS and nNOS expression, and VEGF secretion.
• Stem cell therapy reduced apoptotic cells and improved the smooth muscle to collagen ratio. Modified stem cells demonstrated superior efficacy.

Conclusions:

• Stem cell therapy is a viable strategy for improving erectile function in diabetic rats.
• Specific modifications, such as gene modification with growth factors, enhance therapeutic efficacy.
• Stem cell therapy holds promise as an effective treatment for diabetic ED.